(NYSE: ABBV) announced positive topline results from a phase 1 multiple ascending dose study evaluating ABBV-295, its long-acting amylin analog being developed for obesity and metabolic disease treatment
Manage Oxidative Stress Through Movement Regular, moderate exercise can actually help your body become more efficient at producing antioxidants
Dit product is bedoeld voor: Wetenschappelijke analyse In-vitro studies en experimenteel onderzoek Onderzoek & ontwikkeling (R&D) Analytische toepassingen binnen gecontroleerde onderzoeksomgevingen Onze producten zijn bestemd voor onderzoekers, laboratoria en onderzoeksinstellingen die werken volgens geldende onderzoeksrichtlijnen en veiligheidsprotocollen
Growing innovation in oral peptide formulations, next-generation GLP-1 receptor agonist , and combination peptide therapeutics is increasing the need for advanced peptide synthesis technologies, complex molecular modifications, and flexible commercial-scale manufacturing capabilities
adults, with annual treatment costs climbing sharply across health systems
Kobayashi Y, Tohyama J, Akiyama T, Magara S, Kawashima H, Akasaka N, et al
